期刊文献+

晚期糖基化终产物引起的RhoA和ROCK在人皮肤微血管内皮细胞的分布变化 被引量:2

Advanced Glycation End Products Induced the Redistribution of RhoA and Phosphorylated ROCK in Human Dermal Microvascular Endothelial Cells
下载PDF
导出
摘要 目的观察在晚期糖基化终产物修饰的人血清白蛋白作用下,小G蛋白RhoA及其激活的激酶ROCK在人微血管内皮细胞中分布的变化。方法培养人皮肤微血管内皮细胞株,分别以糖基化修饰的人血清白蛋白(AGE-HSA)处理不同的浓度和时间,用免疫荧光染色法、激光共聚焦显微镜观察RhoA和磷酸化ROCK在细胞中的分布变化;并用活性型RhoA L63或失活型的RhoA N19转染细胞后再给予AGE-HSA刺激,观察磷酸化ROCK细胞内分布的变化。结果 AGE-HSA刺激可以导致RhoA在胞浆中分布增多,其变化随着AGE-HSA作用时间的延长和剂量的增加更加明显。RhoA的下游激酶被活化的磷酸化ROCK在人微血管内皮细胞中的分布与RhoA类似;用失活型RhoAN19先处理细胞后,AGE-HSA介导的ROCK分布变化被抑制。结论晚期糖基化终产物刺激引起小G蛋白RhoA在细胞内分布变化,并导致其下游激酶ROCK磷酸化和定位变化。 Aim To observe the changes of distribution of RhoA and phosphorylated RhoA kinase(ROCK) induced by advanced glycation end products(AGE) in human dermal microvascular endothelial cells(HMVEC-1). Methods Cultured HMVEC-1 were treated with AGE-modified human serum albumin(AGE-HSA).The distribution of RhoA and phospho-ROCK were detected by immunohistochemistry using anti-RhoA and anti-phospho-ROCK antibodies and observed under confocal microscope. Results The data revealed that RhoA located around the nucleus in quiescent HMVEC-1.The stimulation of AGE-HSA evoked an increased distribution of RhoA in cytoplasma,even an accumulation at the cellular edge.The administration of AGE-HSA also triggered a significant increase of phospho-ROCK localization in HMVEC-1 cytoplasma.The transfection of dominant negative RhoA N19 attenuated this AGE-induced phosphor-ROCK spreading while constitutive active RhoA L63 mimiced the AGE-induced response in phospho-ROCK distribution. Conclusion AGE stimulation causes the redistribution of RhoA and results in the phosphorylation of ROCK in human microvascular endothelial cells.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2010年第5期341-344,共4页 Chinese Journal of Arteriosclerosis
基金 国家自然科学基金面上项目(30771028和30971201)
关键词 晚期糖基化终产物 人微血管内皮细胞 RHOA ROCK Advanced Glycation End Products Human Dermal Microvascular Endothelial Cells RhoA ROCK
  • 相关文献

参考文献12

二级参考文献85

共引文献23

同被引文献22

  • 1Pozo M, de Nicolas R, Egido J, et al. Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells [ J ]. Eur J Pharmacol, 2006, 548: 53-63.
  • 2Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25 (9) : 1 767-775.
  • 3Libby P. Inflammation in atherosclerosis [ J ]. Nature, 2002, 420 (6917) : 868-874.
  • 4Keaney JF Jr. Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction [ J ]. Mol Aspects ged, 2000, 21 (4-5) : 99- 166.
  • 5DartAM, Chin-Dusting JPF. Lipids and the endothelium [ J ]. Cardiovoa Res, 1999, 43 (2) : 308-322.
  • 6Etienne-Manneville S, Hall A. Rho GTPases in cell biology [ J ]. Nature, 2002, 420 (6916) : 629-635.
  • 7Dudek SM, Garcia JG. Cytoskeletal regulation of puimonary vascular permeability [ J ]. Appl Physiol, 2001, 91 (4) : 1 487-500.
  • 8Lampugnani MG, Zanetti A, Breviario F, et al. VE-eadherin regulates endothelial acfin activating Rac and increasing membrane association of Tiara [ J ]. Mol Biol Cell, 2002, 13 (4) : 1 175 -189.
  • 9Seebach J, Madler H J, Wojciak-Stothard B, et al. Tyrosine phosphoryla- tion and the small GTPase Rac cross-talk in regulation of endothelial barrier function[J]. Thromb Haemost, 2005, 94 (3) : 620-629.
  • 10Hirooka Y, Shimokawa H. Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases [ J ]. Am J Cardiovasc Drugs, 2005, 5: 31- 39.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部